Fasika Molla Abreha
YOU?
Author Swipe
View article: Economic Impact of Respiratory Syncytial Virus Infections in Children Under 5 Years of Age Attending Primary Care in Italy: A Prospective Cohort Study in Two Regions
Economic Impact of Respiratory Syncytial Virus Infections in Children Under 5 Years of Age Attending Primary Care in Italy: A Prospective Cohort Study in Two Regions Open
Background Accurate cost estimates of respiratory syncytial virus (RSV) infections in primary care are limited, despite the majority of cases being managed in this setting. This study aims to estimate healthcare costs for children with RSV…
View article: Journal of Preventive Medicine and Hygiene, Vol. 63 No. 4S1 (2022): L’Health Technology Assessment come strumento value-based per la valutazione delle tecnologie sanitarie. Reassessment del vaccino antinfluenzale quadrivalente da coltura cellulare: Flucelvax Tetra® 2.0
Journal of Preventive Medicine and Hygiene, Vol. 63 No. 4S1 (2022): L’Health Technology Assessment come strumento value-based per la valutazione delle tecnologie sanitarie. Reassessment del vaccino antinfluenzale quadrivalente da coltura cellulare: Flucelvax Tetra® 2.0 Open
1. Health Technology Assessment: strumento value‐based per la valutazione delle tecnologie sanitarie
\n2. Il burden dell'influenza stagionale in Italia
\n3. Epidemiologia dell’influenza stagionale in Italia
\n4. Vaccini antinfluenzali attu…
View article: The New Quadrivalent Adjuvanted Influenza Vaccine for the Italian Elderly: A Health Technology Assessment
The New Quadrivalent Adjuvanted Influenza Vaccine for the Italian Elderly: A Health Technology Assessment Open
Background. The elderly, commonly defined as subjects aged ≥65 years, are among the at-risk subjects recommended for annual influenza vaccination in European countries. Currently, two new vaccines are available for this population: the MF5…